Stay updated on Nivolumab in Malignant Pleural Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Malignant Pleural Mesothelioma Clinical Trial page.

Latest updates to the Nivolumab in Malignant Pleural Mesothelioma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedNote added that publications are automatically filled from PubMed for this study, and the page revision is updated to v3.3.2. The previous PubMed auto-fill description and v3.2.0 revision text have been removed.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoval of the government funding status banner at the top of the page, a minor UI change that does not affect the study details, criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check42 days agoChange DetectedNo significant changes detected between the old and new screenshots; the study details, eligibility criteria, and locations appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedMajor change: updated operating status notice and version to v3.2.0, replacing v3.1.0; outlines funding lapse effects and where to check details.SummaryDifference3%

- Check78 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; 'Back to Top' link removed; no substantive content changes detected.SummaryDifference0.2%

Stay in the know with updates to Nivolumab in Malignant Pleural Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Malignant Pleural Mesothelioma Clinical Trial page.